Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma

  • Authors:
    • Xiaoxue Xie
    • Hekun Jin
    • Jun Hu
    • Yong Zeng
    • Jumei Zhou
    • Shuyu Ouyang
    • Wenjuan Yang
    • Bingqiang Hu
    • Hui Wang
  • View Affiliations

  • Published online on: October 24, 2013     https://doi.org/10.3892/or.2013.2808
  • Pages: 223-231
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Single nucleotide polymorphisms (SNPs) in the p53, MDM2 and p21 genes of the p53 pathway have been extensively studied. The main aim of the current retrospective study was to evaluate the possible predictive value of SNPs in the p53 pathway in locoregionally advanced nasopharyngeal carcinoma (NPC) in response to radiotherapy. In total, 75 consecutive patients with locoregionally advanced NPC were enrolled. Three SNPs in the p53 pathway were identified using the Sanger sequencing method from retrospectively collected paraffin-embedded biopsy specimens. The effects of genetic polymorphisms on patient progression‑free survival (PFS) were analyzed using the Cox proportional hazards model, Kaplan-Meier method and log-rank test. All of the selected subjects completed questionnaires on smoking habits prior to treatment. Multivariate analysis showed that the p53 codon 72 Pro/Pro genotype [hazard ratio (HR), 0.300; 95% confidence interval (CI), 0.092-0.983; P=0.047] and heavy smoking (≥30 pack-years) (HR, 2.899; 95% CI, 1.349-6.229; P=0.006) are independent significant prognostic factors for PFS in patients with locoregionally advanced NPC. Moreover, mean times to disease progression for heavy smokers (≥20 pack-years) carrying p53 codon 72 Arg/Arg, p21 codon 31 Arg/Arg and MDM2 309 SNP G/G genotypes were only 14.78±3.00, 11.00±0.58 and 11.17±1.85 months, respectively. These time scales were less than half of those recorded for patients containing other genotypes and moderate smokers (<20 pack-years). In conclusion, the p53 codon 72 polymorphism is an independent prognostic marker for locoregionally advanced NPC. Moreover, analysis of SNPs in the p53 pathway may facilitate the identification of patients at high risk of poor disease outcome in subgroups of heavy smokers.
View Figures
View References

Related Articles

Journal Cover

2014-January
Volume 31 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xie X, Jin H, Hu J, Zeng Y, Zhou J, Ouyang S, Yang W, Hu B and Wang H: Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma. Oncol Rep 31: 223-231, 2014
APA
Xie, X., Jin, H., Hu, J., Zeng, Y., Zhou, J., Ouyang, S. ... Wang, H. (2014). Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma. Oncology Reports, 31, 223-231. https://doi.org/10.3892/or.2013.2808
MLA
Xie, X., Jin, H., Hu, J., Zeng, Y., Zhou, J., Ouyang, S., Yang, W., Hu, B., Wang, H."Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma". Oncology Reports 31.1 (2014): 223-231.
Chicago
Xie, X., Jin, H., Hu, J., Zeng, Y., Zhou, J., Ouyang, S., Yang, W., Hu, B., Wang, H."Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma". Oncology Reports 31, no. 1 (2014): 223-231. https://doi.org/10.3892/or.2013.2808